BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders
03 janv. 2024 07h00 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (Nasdaq: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...